Dilafor AB’s SEK 23.3 Million Financing Round

Vinge and Nctm Studio Legale advised Opocrin S.p.A. on the deal. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Dilafor AB has completed…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here